Prophylactic anticoagulation following the Fontan operation

Heart

Volumn 91, Issue 7, 2005, Pages 854-856

  Walker, H A ^a   Gatzoulis, Michael A ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 8; PROTEIN C; PROTEIN S; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; CARDIOVASCULAR SURGERY; DRUG INDICATION; FONTAN PROCEDURE; HEART ATRIUM ARRHYTHMIA; HUMAN; INTRACARDIAC THROMBOSIS; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN TIME; REVIEW; RISK; SCREENING TEST; SURGICAL MORTALITY; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ANTICOAGULANTS; ARRHYTHMIA; ASPIRIN; FONTAN PROCEDURE; HEART DISEASES; HUMANS; POSTOPERATIVE CARE; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 21044457379     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.039073     Document Type: Review

References (27)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971;26:240-8.
2. Larda AC, del Nido PJ, Webber SA, et al. Hemodynamic effect of progressive right atrial dilatation in atriopulmonary connections. J Thorac Cardiovasc Surg 1997;114:2-8.
3. Kawashima Y, Kitamura S, Matsuda H, et al. Total cavopulmonary shunt operation in complex cardiac anomalies. J Thorac Cardiovasc Surg 1984;87:74-81.
4. Monagle P, Cochrane A, McCrindle, et al. Thromboembolic complications after Fontan procedures - the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 1998;115:493-8.
5. Van den Bosch AE, Roos-Hesselink JW, Van Domberg, et al. Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol 2004;93:1141-5.
6. Jahangiri M, Ross DB, Redingtan AN, et al. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 1994;58:1409-13.
7. Rosenthal DN, Friedman AH, Kleinman CS, et al. Thromboembolic complications after Fontan operations. Circulation 1995;92:II287-93.
8. Coon PD, Rychik J, Novelle RT, et al. Thrombus formation after the Fontan operation. Ann Thorac Surg 2001;71:1990-4.
9. Balling G, Vogt M, Kaemmerer H, et al. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 2000;119:745-52.
10. Varma C, Warr MR, Hendler AL, et al. Prevalence of "silent" pulmonary emboli in adults after the Fontan operation. J Am Coll Cardiol 2003;41:2252-8.
11. Seipelt RG, Franke A, Vazquez-Jimenez JF, et al. Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 2002;74:556-62.
12. Jacobs ML, Pourmoghadam KK, Geary EM, et al. Fontan's operation: Is aspirin enough? Is coumadin too much? Ann Thorac Surg 2002;73:64-8.
13. Hanseus K, Björkheim G, Sorenson GK, et al. Formation of thrombus and thromboembolism after the bidirectional Glenn anastomosis, tatal cavopulmonary connection and the Fontan operation. Cardiol Young 1998;8:211-6.
14. du Plessis A, Chang A, Wessel D, et al. Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 1995;12:230-6.
15. Konstantinov IE, Puga FJ, Alexi-Meskishvili VV. Thrombosis of intracardiac or extracardiac conduits after modified Fontan operation in patients with azygous continuation of the inferior vena cava. Ann Thorac Surg 2001;72:1641-4.
16. Chun DS, Schamberger MS, FlaspohlerT, et al. Incidence, outcome, and risk factors far stroke after the Fontan procedure. Am J Cardiol 2004;93:117-9.
17. Wong T, Davlouros PA, Li W, et al. Mechano-electrical interaction late after Fontan operation: relation between p-wave duration and dispersion, right atrial size, and atrial arrhythmias. Circulation 2004;109:2319-25, Epub 2004 May 10.
18. Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, et al. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990;336:1087-90.
19. Odegard KC, McGowan FX, DiNardo JA, et al. Coagulation abnormalities in patients with single ventricle physiology precede Fontan procedure. J Thorac Cardiovasc Surg 2002;123:459-65.
20. Odegard KC, McGowan FX, Zurakowski D, et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 2003;125:1260-7.
21. Jahangiri M, Kreutzer J, Zurakowski D, et al. Evaluation of hemostatic and coagulation factors abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 2000;120:778-82.
22. Ravn HB, Hjortdal VE, Stenbog EV, et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2001;85:61-5.
23. Kaulitz R, Luhmer I, Bergmann F, et al. Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 1997;78:154-9.
24. Narkewicz MR, Sondheiner HM, Ziegler JW, et al. Hepotic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 1996;23:352-7.
25. Nieuwenhuizen RC, Peters M, Lubbers LJ, et al. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 1999;82:40-6.
26. Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemoaynamics following Fontan-type operations. Cardiol Young 2001;11:62-6.
27. Strief W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999;94:3007-14.